肝脏成像与活检在临床实践中的应用 - Suppr | 超能文献

相似文献

1

Use of Liver Imaging and Biopsy in Clinical Practice.肝脏成像与活检在临床实践中的应用

N Engl J Med. 2017 Dec 7;377(23):2296-2297. doi: 10.1056/NEJMc1712445.

2

[Present situation on non-invasive assessment of liver fibrosis/cirrhosis].[肝纤维化/肝硬化的非侵入性评估现状]

Zhonghua Gan Zang Bing Za Zhi. 2018 May 20;26(5):325-327. doi: 10.3760/cma.j.issn.1007-3418.2018.05.002.

3

Ultrasonography is not reliable in diagnosing liver cirrhosis in clinical practice.在临床实践中，超声检查在诊断肝硬化方面并不可靠。

Singapore Med J. 2003 Jun;44(6):293-5.

4

Histopathologic evaluation of liver biopsy for cirrhosis.肝硬化肝活检的组织病理学评估。

Adv Anat Pathol. 2012 Jul;19(4):220-30. doi: 10.1097/PAP.0b013e31825c6bab.

5

Science to Practice: Can MR imaging replace liver biopsy for the diagnosis of early fibrosis?

Radiology. 2006 May;239(2):309-10. doi: 10.1148/radiol.2392051872.

6

[LAPAROSCOPIC EXPLORATIONS AND PUNCTURE BIOPSY OF THE LIVER IN HEPATIC CIRRHOSIS].

Rev Int Hepatol. 1963;13:645-54.

7

Non-invasive diagnosis of advanced fibrosis and cirrhosis.晚期纤维化和肝硬化的非侵入性诊断

World J Gastroenterol. 2014 Dec 7;20(45):16820-30. doi: 10.3748/wjg.v20.i45.16820.

8

Use of Liver Imaging and Biopsy in Clinical Practice.肝脏成像与活检在临床实践中的应用。

N Engl J Med. 2017 Aug 24;377(8):756-768. doi: 10.1056/NEJMra1610570.

9

[Are non-invasive tests going to replace liver biopsy for diagnosis of liver fibrosis?].[非侵入性检查会取代肝活检用于肝纤维化的诊断吗？]

Rev Med Suisse. 2012 Jun 27;8(347):1411-5.

10

[Comparison of laparoscopic and scintigraphic findings in chronic hep-titis, liver cirrhosis and liver tumours (author's transl)].

Dtsch Med Wochenschr. 1975 Jan 24;100(4):129-32. doi: 10.1055/s-0028-1106182.

引用本文的文献

1

S index: a predictor comparable to ultrasound shear wave elastography in assessing liver fibrosis in patients with chronic hepatitis B.S指数：一种在评估慢性乙型肝炎患者肝纤维化方面可与超声剪切波弹性成像相媲美的预测指标。

BMC Med Imaging. 2025 Jul 28;25(1):296. doi: 10.1186/s12880-025-01846-3.

2

Serum/Plasma Proteome in Non-Malignant Liver Disease.非恶性肝脏疾病的血清/血浆蛋白质组。

Int J Mol Sci. 2024 Feb 7;25(4):2008. doi: 10.3390/ijms25042008.

3

Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma.